Treatment of overactive bladder: The antimuscarinic clinical effectiveness trial Rodney A. Appell Clinical Trials Report Pages: 343 - 344
De novo urge syndrome and detrusor instability after anti-incontinence surgery: Current concepts, evaluation, and treatment Richard T. KershenRodney A. Appell OriginalPaper Pages: 345 - 353
Management of urinary retention and obstruction following surgery for stress urinary incontinence Harriette M. ScarperoVictor W. Nitti OriginalPaper Pages: 354 - 359
Treatment of postprostatectomy incontinence: Is the bulbourethral sling a viable alternative to the artificial urinary sphincter? Steven P. Petrou OriginalPaper Pages: 360 - 364
Pharmacologic treatment for detrusor overactivity H. Henry LaiTimothy B. BooneRodney A. Appell OriginalPaper Pages: 365 - 372
Impaired detrusor contractility: Anything new? Shahar MadjarRodney A. Appell OriginalPaper Pages: 373 - 377
Radiofrequency bladder neck suspension for the treatment of genuine stress urinary incontinence Roger R. Dmochowski OriginalPaper Pages: 378 - 381
Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction Christopher P. SmithGeorge T SomogyiMichael B. Chancellor OriginalPaper Pages: 382 - 387
Surgical management of overactive bladder Michael GrossTimothy B. BooneRodney A. Appell OriginalPaper Pages: 388 - 395
Autologous fat injections for the treatment of female stress urinary incontinence Philippe E. Zimmern Clinical Trials Report Pages: 399 - 399
A new injectable bulking agent for the treatment of female stress urinary incontinence Philippe E. Zimmern Clinical Trials Report Pages: 400 - 400
Injectable agents: Present and future Deborah J. LightnerNancy B. ItanoFelecia Fick OriginalPaper Pages: 408 - 413
